Spots Global Cancer Trial Database for gastrointestinal cancer
Every month we try and update this database with for gastrointestinal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | NCT00516269 | Breast Cancer Fatigue Gastrointestina... | Methylphenidate Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels | NCT04931420 | Metastatic Canc... Foregut Carcino... Gastric Adenoca... Gallbladder Ade... Liver Cancer GI Cancer GI Carcinoma Lung Cancer | Standard of Car... Video-Assisted ... Lobectomy Consolidative R... Ablation Treatm... Resection or Ex... Peritonectomy Transarterial R... | 18 Years - | University of Chicago | |
| Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | NCT03515941 | Gastrointestina... | Oxaliplatin Capecitabine Leucovorin 5-fluorouracil radiation | 18 Years - | Baylor College of Medicine | |
| Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer) | NCT04611035 | Gastrointestina... | QPOP | 21 Years - 99 Years | National University Hospital, Singapore | |
| Next-generation Sequencing in Gastrointestinal Cancer | NCT03476057 | Gastrointestina... | Device： NGS seq... | - | Fujian Cancer Hospital | |
| Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI | NCT05381038 | Solid Tumor Gastrointestina... Breast Cancer | QPOP CURATE.AI Azacitidine + d... Azacitidine + p... Azacitidine + i... | 21 Years - 99 Years | National University Hospital, Singapore | |
| ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy | NCT05318027 | Lung Cancer Gastrointestina... Head and Neck C... | ChatBot | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers | NCT00716209 | Gastrointestina... | 18 Years - | National University Hospital, Singapore | ||
| An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal | NCT05225844 | Gastrointestina... Immunotherapy Targeted Therap... | Camrelizumab Apatinib Mesyla... | 18 Years - 75 Years | Harbin Medical University | |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors | NCT04354064 | Healthy Volunte... Prostate Cancer Head and Neck C... Esophageal Canc... Genitourinary C... Sarcoma Breast Cancer Colon Cancer Gastrointestina... Solid Tumor Can... Lung Cancer Skin Cancer Melanoma | 18 Years - | Washington University School of Medicine | ||
| Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia | NCT04131426 | Cachexia; Cance... Weight Loss Lung Cancer Gastrointestina... | Remune EXCAP©® | 18 Years - | University of Rochester | |
| Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study | NCT05158907 | Gastrointestina... | Patient reporte... | 18 Years - | Tata Medical Center | |
| Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen | NCT04680104 | Gastrointestina... CALCIUM LEVOFOL... SODIUM LEVOFOLI... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | ||
| Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology | NCT05664178 | Gastrointestina... | Tele-Resistance... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer | NCT03343301 | Gastrointestina... Gastrointestina... Gastric Cancer | Bemarituzumab Modified FOLFOX... | 18 Years - | Five Prime Therapeutics, Inc. | |
| COMplementary Hand-foot Massage to Improve Experience of illneSs Trial | NCT02741401 | Gastrointestina... | Usual post-oper... Hand-foot massa... | 18 Years - | Zuyderland Medisch Centrum | |
| the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin | NCT05494320 | Gastrointestina... | Folfox Protocol | 18 Years - | Ain Shams University | |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | NCT04426669 | Gastrointestina... Gastrointestina... Cancer of Gastr... Cancer, Gastroi... Gastrointestina... Colo-rectal Can... Pancreatic Canc... Gall Bladder Ca... Colon Cancer Esophageal Canc... Stomach Cancer | Cyclophosphamid... Fludarabine Tumor-Infiltrat... Aldesleukin | 18 Years - 70 Years | Intima Bioscience, Inc. | |
| Biomarker Analysis of Gastrointestinal Cancer | NCT01484444 | Gastrointestina... | 18 Years - | Samsung Medical Center | ||
| 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers | NCT05113264 | Gastrointestina... | 'Penny' via Mem... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Harvesting Cells for Experimental Cancer Treatments | NCT00068003 | Melanoma Gastrointestina... Metastatic Canc... Breast Cancer Non-Small Cell ... | Anti-CD19 CAR P... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Improving Comprehensive Care of Cancer Patients | NCT05323409 | Breast Cancer Gastrointestina... Hematologic Can... | OPTIMISE | 18 Years - | Baylor College of Medicine | |
| EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | NCT03602885 | Metastatic Panc... Unresectable Pa... Metastatic Colo... | Usual chemother... Chemotherapy ed... | 21 Years - | Dana-Farber Cancer Institute | |
| Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer | NCT03915171 | Gastrointestina... | Next generation... | 18 Years - | China Medical University, China | |
| SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | NCT05375643 | Gastrointestina... Hematologic Can... Thoracic Cancer | SURGE | 18 Years - | Dana-Farber Cancer Institute | |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers | NCT01445327 | Esophageal Canc... Stomach Cancer Pancreatic Canc... | Specimen collec... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) | NCT02583815 | Gastrointestina... Breast Cancer Gynecologic Can... Genitourinary C... Leukemia Lung Cancer Skin Cancer Endocrine Cance... Male Genital Ca... | 18 Years - | University of Texas Southwestern Medical Center | ||
| Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies | NCT05743426 | Sarcoma Gastrointestina... | Survey Toxicity Assess... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer | NCT03286348 | Nutritional Sta... Gastrointestina... Chemoradiothera... | 18 Years - 70 Years | Fudan University | ||
| Patient Factors Impacting Adherence to Oral Chemotherapy | NCT01487343 | Breast Cancer Gastrointestina... | questionnaire a... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder | NCT00085410 | Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Gastrointestina... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ultrasound | NCT02818530 | Urological Canc... Gastrointestina... Malignant Femal... | IOP by tonomete... Anterior chambe... | 18 Years - 70 Years | Tata Memorial Centre | |
| Nutrition and Physical Exercise Study | NCT01540968 | Gastrointestina... Lung Cancer | Nutrition & phy... | 18 Years - | Kantonsspital Winterthur KSW | |
| Improving Cancer Symptom Management | NCT04589247 | Cancer Thoracic Neopla... Gastrointestina... Lung Cancer | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | ||
| A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy | NCT01624220 | Spinal Tumor | Spinal SBRT (St... Spinal SBRT (Hi... Gold Seed Impla... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy | NCT06362070 | Gastric Cancer Gastrointestina... Neoplasms Gastric Diffuse... Gastric Neoplas... Stomach Adenoca... | DaVinci® Surgic... Hugo™ RAS Syste... Versius® Roboti... | 18 Years - 80 Years | Azienda Ospedaliera Universitaria Integrata Verona | |
| Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population | NCT05863052 | Immune Checkpoi... Metastatic Soli... Nonsmall Cell L... Melanoma Renal Cell Carc... Gastrointestina... Squamous Cell C... | Immunotherapy | 18 Years - 99 Years | University of Oklahoma | |
| Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract | NCT00353015 | Gastrointestina... Carcinoma, Neur... | Cisplatin Irinotecan | - | M.D. Anderson Cancer Center | |
| Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) | NCT05629065 | Breast Cancer Gastrointestina... Gynecologic Can... Thoracic Cancer Genitourinary C... | Clinician Nudge... Patient Nudge L... | 18 Years - | Dana-Farber Cancer Institute | |
| Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer | NCT03665714 | Gastrointestina... | Impact Oral Enteral Nutriti... | 18 Years - 75 Years | Société des Produits Nestlé (SPN) | |
| NextSteps Intervention for Advanced Cancer Patients and Caregivers | NCT04885439 | Lung Cancer Gastrointestina... | NextSteps | 18 Years - | Baylor College of Medicine | |
| Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy | NCT01422993 | Neuropathy Gastrointestina... | 12 Week Exercis... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer | NCT03076502 | Neoplasms, Gast... | 18 Years - 80 Years | RenJi Hospital | ||
| Adapting the Tumor Board Model for Mental Illness and Cancer | NCT05837598 | Cancer Severe Major De... Schizophrenia Bipolar Disorde... Lung Cancer Breast Cancer Head and Neck C... Gastrointestina... Genitourinary C... | Virtual Cancer ... | 18 Years - | Massachusetts General Hospital | |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | NCT05411133 | Gastrointestina... Cholangiocarcin... Liver Cancer Colorectal Aden... Pancreatic Canc... Gastric Cancer Esophageal Aden... Gastroesophagea... | Cabotamig (ARB2... | 18 Years - | Arbele Limited | |
| Nutritional Risk Screening Nutritional Support Gastrointestinal Cancer | NCT06018246 | Gastrointestina... | Malnutrition fi... Conventional nu... | 18 Years - | The First Affiliated Hospital of Shanxi Medical University | |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | NCT06263088 | Gastrointestina... Colon Cancer Rectal Cancer Anal Cancer Esophageal Canc... Stomach Cancer Appendix Cancer Pancreas Cancer Liver Cancer Neuroendocrine ... | EQUITY GI | 18 Years - | Case Comprehensive Cancer Center | |
| Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention | NCT06168825 | Cancer Breast Cancer Brain Cancer Central Nervous... Colorectal Canc... Esophageal Canc... Gynecologic Can... Head and Neck C... Gastrointestina... Genitourinary C... Melanoma Blood Cancer Lung Cancer Acceptance and ... Mind-Body Thera... Psychosocial In... | Mind Over Matte... | 18 Years - | Inova Health Care Services | |
| CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater | NCT01202409 | Gastrointestina... | Panitumumab | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors | NCT00921869 | Solid Tumors | E7050 | 20 Years - 74 Years | Eisai Inc. | |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | NCT03190941 | Pancreatic Canc... Gastric Cancer Gastrointestina... Colon Cancer Rectal Cancer | Cyclophosphamid... Fludarabine Anti-KRAS G12V ... Aldesleukin | 18 Years - 72 Years | National Institutes of Health Clinical Center (CC) | |
| Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations | NCT05651672 | Gastrointestina... | Pemigatinib | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer | NCT03665714 | Gastrointestina... | Impact Oral Enteral Nutriti... | 18 Years - 75 Years | Société des Produits Nestlé (SPN) | |
| Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy | NCT03958747 | Gastrointestina... Colorectal Canc... | Ultrasound - Se... Skin Biopsy Abbreviated Neu... Blood draw Nerve Conductio... QLQ-CIPN20 Ques... | 18 Years - | Wake Forest University Health Sciences | |
| Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation | NCT00452205 | Gastrointestina... | 20 Years - 70 Years | Komagome Hospital | ||
| Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery | NCT04189393 | Gastrointestina... Colorectal Canc... Pancreatic Canc... Esophageal Canc... Rectum Neoplasm Esophageal Neop... Pancreatic Duct... Colonic Neoplas... Gastrointestina... Microbiota Anastomotic Lea... | 18 Years - | Radboud University Medical Center | ||
| Nutritional Risk Screening Nutritional Support Gastrointestinal Cancer | NCT06018246 | Gastrointestina... | Malnutrition fi... Conventional nu... | 18 Years - | The First Affiliated Hospital of Shanxi Medical University | |
| Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms | NCT04363983 | Gastrointestina... | Blood sampling Liver biopsy Stool collect | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer | NCT05606848 | Gastrointestina... | Nutrition Emuls... Foods for speci... | 18 Years - 75 Years | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | |
| HYPAZ: Hypertension Induced by Pazopanib | NCT01392352 | Renal Cell Carc... Soft Tissue Sar... Glioblastoma Ovarian Cancer Cervical Cancer Breast Cancer Non-small Cell ... Small Cell Lung... Pancreatic Canc... Melanoma Gastrointestina... | Pazopanib | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer | NCT01313442 | Non-GI Cancers Cancer of Gastr... Gastrointestina... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement | NCT04879927 | Breast Cancer Lung Cancer Gastrointestina... | Resource Matchi... Usual Care | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | NCT03597581 | Gastrointestina... Gastrointestina... Colorectal Canc... Colorectal Neop... Colorectal Carc... Gastric Cancer Gastric Neoplas... KRAS Mutation-R... CRC Colorectal Canc... | ompenaclid FOLFIRI Bevacizumab FOLFOX regimen | 18 Years - | Inspirna, Inc. | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| Avatrombopag vs. Placebo for CIT in GI Malignancies | NCT05772546 | Gastrointestina... Gastrointestina... Chemotherapy-In... | Avatrombopag Matching Placeb... | 18 Years - | Massachusetts General Hospital | |
| Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | NCT03300843 | Melanoma Gastrointestina... Breast Cancer Ovarian Cancer Pancreatic Canc... | Peptide loaded ... | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Seal-G / Seal-G MIST Study | NCT04532515 | Colon Cancer Gastrointestina... | Seal-G Surgical... Seal-G MIST Sys... | 18 Years - 80 Years | Advanced Medical Solutions Ltd. | |
| Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery | NCT02975661 | Gastrointestina... | 18 Years - 70 Years | Qidong Gaitianli Medicines Co., Ltd | ||
| BGT007 Cells for the Treatment of Refractory Digestive System Tumors | NCT06104241 | Gastrointestina... | BGT007 Injectio... | 18 Years - 70 Years | The Affiliated Hospital of Xuzhou Medical University | |
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity | NCT04273061 | Breast Cancer Lung Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Sarcoma Unknown Primary... Head and Neck C... Skin Cancer | Atezolizumab | 18 Years - | British Columbia Cancer Agency | |
| Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI | NCT05381038 | Solid Tumor Gastrointestina... Breast Cancer | QPOP CURATE.AI Azacitidine + d... Azacitidine + p... Azacitidine + i... | 21 Years - 99 Years | National University Hospital, Singapore | |
| Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers | NCT01375699 | Breast Cancer Gastrointestina... Genitourinary C... Sarcoma Gynecologic Can... | Doxorubicin Sildenafil | 18 Years - | Virginia Commonwealth University | |
| Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer | NCT04081831 | Gastrointestina... | Acetylsalicylic... | 40 Years - | Bayer | |
| Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen | NCT04680104 | Gastrointestina... CALCIUM LEVOFOL... SODIUM LEVOFOLI... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | ||
| A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors | NCT05001347 | Ovarian Cancer Head and Neck C... Non Small Cell ... Gastrointestina... Triple Negative... Ovarian Carcino... | TJ004309 | 18 Years - | I-Mab Biopharma US Limited | |
| Collecting Solid Tumor Tissue to Identify New Treatments | NCT01658917 | Gastrointestina... Liver Cancer Pancreatic Canc... Melanoma | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Biomarker Analysis of Gastrointestinal Cancer | NCT01484444 | Gastrointestina... | 18 Years - | Samsung Medical Center | ||
| Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors | NCT00356889 | Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | erlotinib hydro... bevacizumab | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
